Latest Insider Transactions at Landos Biopharma, Inc. (LABP)
This section provides a real-time view of insider transactions for Landos Biopharma, Inc. (LABP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Landos Biopharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Landos Biopharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 28
2023
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,720,868
-100.0%
|
-
|
|
Sep 23
2022
|
Rtw Investments, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300,000
-7.02%
|
$0
$0.69 P/Share
|
|
Aug 05
2022
|
Josep Bassaganya Riera > 10% Shareholder |
BUY
Bona fide gift
|
Indirect |
500,000
+50.0%
|
-
|
|
Aug 05
2022
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
500,000
-12.52%
|
-
|
|
Dec 20
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
33,194
-0.66%
|
$132,776
$4.75 P/Share
|
|
Dec 17
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,000
-0.71%
|
$144,000
$4.84 P/Share
|
|
Dec 16
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,301
-0.48%
|
$121,505
$5.11 P/Share
|
|
Dec 16
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
58,651
-1.14%
|
-
|
|
Dec 15
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
43,000
-0.83%
|
$215,000
$5.02 P/Share
|
|
Dec 14
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,000
-0.8%
|
$210,000
$5.1 P/Share
|
|
Dec 13
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,000
-0.76%
|
$200,000
$5.37 P/Share
|
|
Dec 10
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
40,000
-0.75%
|
$200,000
$5.77 P/Share
|
|
Dec 09
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,162
-0.21%
|
$66,972
$6.26 P/Share
|
|
Dec 08
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,530
-0.48%
|
$153,180
$6.65 P/Share
|
|
Dec 07
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
42,000
-0.78%
|
$252,000
$6.58 P/Share
|
|
Dec 06
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,000
-0.66%
|
$216,000
$6.17 P/Share
|
|
Dec 03
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Bona fide gift
|
Indirect |
1,869,008
-13.75%
|
-
|
|
Dec 03
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,000
-0.49%
|
$216,000
$6.15 P/Share
|
|
Dec 02
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
29,861
-0.41%
|
$179,166
$6.45 P/Share
|
|
Dec 01
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,237
-0.44%
|
$225,659
$7.01 P/Share
|
|
Nov 30
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,000
-0.47%
|
$245,000
$7.06 P/Share
|
|
Nov 29
2021
|
Josep Bassaganya Riera > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,430
-0.21%
|
$108,010
$7.58 P/Share
|
|
Jul 26
2021
|
Jyoti Chauhan ED, Global Clinical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
118,054
+36.06%
|
$118,054
$1.86 P/Share
|
|
Feb 09
2021
|
Konstantin Poukalov Director |
BUY
Open market or private purchase
|
Indirect |
99,681
+0.33%
|
$1,395,534
$14.2 P/Share
|
|
Feb 09
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
99,681
+0.68%
|
$1,395,534
$14.2 P/Share
|
|
Feb 08
2021
|
Konstantin Poukalov Director |
BUY
Open market or private purchase
|
Indirect |
1,373,053
+2.18%
|
$17,849,689
$13.25 P/Share
|
|
Feb 08
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,373,053
+4.19%
|
$17,849,689
$13.25 P/Share
|
|
Feb 08
2021
|
Konstantin Poukalov Director |
BUY
Conversion of derivative security
|
Indirect |
13,369,728
+50.0%
|
-
|
|
Feb 08
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
13,369,728
+43.2%
|
-
|
|
Feb 08
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,650,722
+46.06%
|
-
|
|
Feb 05
2021
|
Konstantin Poukalov Director |
BUY
Open market or private purchase
|
Indirect |
27,453
+0.19%
|
$301,983
$11.14 P/Share
|
|
Feb 05
2021
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
27,453
+0.39%
|
$301,983
$11.14 P/Share
|
|
Feb 04
2021
|
Rtw Investments, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+50.0%
|
$10,000,000
$16.0 P/Share
|